ea0070aep180 | Bone and Calcium | ECE2020
L Clarke Bart
, Rejnmark Lars
, Ing Steven
, Luisa Brandi Maria
, Björnsdottir Sigridur
, Hahner Stefanie
, Hofbauer Lorenz C
, Houillier Pascal
, Khan Aliya A
, Levine Michael A
, Mannstadt Michael
, M Shoback Dolores
, Vokes Tamara J
, Zhang Pinggao
, Marelli Claudio
, Germak John
, Gittoes Neil
PARADIGHM is an actively recruiting, prospective, observational registry (NCT01922440/EUPAS16927). The primary objective is to evaluate the safety and effectiveness of recombinant human parathyroid hormone, rhPTH(1-84), treatment in patients with chronic hypoparathyroidism under routine clinical care. The secondary objective is tocharacterize the clinical course of chronic hypoparathyroidism under conditions of routine clinical practice. At enrollment, registry inclusion crite...